Security key
92337R101
Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)
CUSIP: 92337R101
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Class A Common Stock, par value $0.001 per share
- Shares outstanding
- 72,325,000
- Total 13F shares
- 62,912,622
- Share change
- +9,248,157
- Total reported value
- $2,660,465,176
- Put/Call ratio
- 167%
- Price per share
- $42.29
- Number of holders
- 177
- Value change
- +$389,856,746
- Number of buys
- 118
- Number of sells
- 59
Report period
Q4 2024
Institutions
177
Top holders
10
VERA full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Vera Therapeutics, Inc. SEC filings
Vera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92337R101
Recent filing periods:
Top shareholders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
13F
13D/G
3/4/5
Evidence coverage
50 holder rows
Latest evidence as of 30 Sep 2024.
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC |
13F
13D/G
Company
|
8.9%
from 13D/G
|
$190,483,878
4,309,590 shares
|
— | 30 Sep 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
5.4%
|
$174,109,000
3,939,109 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
4.8%
|
$152,587,327
3,452,202 shares
|
— | 30 Sep 2024 |
| Sofinnova Investments, Inc. |
13F
Company
|
3.9%
|
$123,494,225
2,793,987 shares
|
— | 30 Sep 2024 |
| FMR LLC |
13F
Company
|
3.9%
|
$123,109,553
2,785,284 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.6%
|
$114,043,824
2,580,177 shares
|
— | 30 Sep 2024 |
| Commodore Capital LP |
13F
3/4/5
Company · 10%+ Owner
|
3.4%
|
$109,395,000
2,475,000 shares
|
— | 30 Sep 2024 |
| Eversept Partners, LP |
13F
Company
|
2.8%
|
$90,616,939
2,050,157 shares
|
— | 30 Sep 2024 |
| Holocene Advisors, LP |
13F
Company
|
2.7%
|
$86,390,138
1,954,528 shares
|
— | 30 Sep 2024 |
| STATE STREET CORP |
13F
Company
|
2.5%
|
$80,612,269
1,823,807 shares
|
— | 30 Sep 2024 |
| Kynam Capital Management, LP |
13F
Company
|
2.2%
|
$69,683,466
1,576,549 shares
|
— | 30 Sep 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
1.9%
|
$60,730,800
1,374,000 shares
|
— | 30 Sep 2024 |
| SAMLYN CAPITAL, LLC |
13F
Company
|
1.9%
|
$60,077,835
1,359,227 shares
|
— | 30 Sep 2024 |
| Paradigm Biocapital Advisors LP |
13F
Company
|
1.5%
|
$48,480,814
1,096,851 shares
|
— | 30 Sep 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.4%
|
$44,414,947
1,004,665 shares
|
— | 30 Sep 2024 |
| Woodline Partners LP |
13F
Company
|
1.4%
|
$44,239,471
1,000,893 shares
|
— | 30 Sep 2024 |
| T. Rowe Price Investment Management, Inc. |
13F
Company
|
1.4%
|
$43,493,000
984,001 shares
|
— | 30 Sep 2024 |
| Siren, L.L.C. |
13F
Individual
|
1.2%
|
$37,036,418
837,928 shares
|
— | 30 Sep 2024 |
| DEUTSCHE BANK AG\ |
13F
Company
|
1.1%
|
$33,881,245
766,544 shares
|
— | 30 Sep 2024 |
| First Light Asset Management, LLC |
13F
Company
|
0.98%
|
$31,171,343
705,234 shares
|
— | 30 Sep 2024 |
| Altium Capital Management LLC |
13F
Company
|
0.95%
|
$30,232,800
684,000 shares
|
— | 30 Sep 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
0.93%
|
$29,873,542
675,872 shares
|
— | 30 Sep 2024 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
0.83%
|
$26,513,547
599,854 shares
|
— | 30 Sep 2024 |
| MARSHALL WACE, LLP |
13F
Company
|
0.81%
|
$25,800,645
583,725 shares
|
— | 30 Sep 2024 |
| Pictet Asset Management Holding SA |
13F
Company
|
0.79%
|
$25,282,312
571,998 shares
|
— | 30 Sep 2024 |
| Integral Health Asset Management, LLC |
13F
Company
|
0.69%
|
$22,100,000
500,000 shares
|
— | 30 Sep 2024 |
| Logos Global Management LP |
13F
Company
|
0.69%
|
$22,100,000
500,000 shares
|
— | 30 Sep 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
Company
|
0.66%
|
$20,708,413
476,713 shares
|
— | 30 Sep 2024 |
| S.c.a. Candriam |
13F
Individual
|
0.62%
|
$19,932,953
450,992 shares
|
— | 30 Sep 2024 |
| JENNISON ASSOCIATES LLC |
13F
Company
|
0.62%
|
$19,761,731
447,098 shares
|
— | 30 Sep 2024 |
| Affinity Asset Advisors, LLC |
13F
Company
|
0.6%
|
$19,227,000
435,000 shares
|
— | 30 Sep 2024 |
| LORD, ABBETT & CO. LLC |
13F
Company
|
0.59%
|
$18,830,000
426,014 shares
|
— | 30 Sep 2024 |
| FEDERATED HERMES, INC. |
13F
Company
|
0.57%
|
$18,303,441
414,105 shares
|
— | 30 Sep 2024 |
| AMERICAN CENTURY COMPANIES INC |
13F
Company
|
0.53%
|
$17,079,556
386,414 shares
|
— | 30 Sep 2024 |
| Rock Springs Capital Management LP |
13F
Company
|
0.53%
|
$16,950,346
383,492 shares
|
— | 30 Sep 2024 |
| NORTHERN TRUST CORP |
13F
Company
|
0.51%
|
$16,146,260
365,300 shares
|
— | 30 Sep 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
Company
|
0.5%
|
$15,991,781
361,805 shares
|
— | 30 Sep 2024 |
| MORGAN STANLEY |
13F
Company
|
0.47%
|
$15,075,561
341,076 shares
|
— | 30 Sep 2024 |
| First Turn Management, LLC |
13F
Company
|
0.45%
|
$14,431,035
326,494 shares
|
— | 30 Sep 2024 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
0.41%
|
$13,102,427
296,435 shares
|
— | 30 Sep 2024 |
| AXA S.A. |
13F
Company
|
0.34%
|
$10,885,090
246,269 shares
|
— | 30 Sep 2024 |
| Alphabet Inc. |
13F
Company
|
0.33%
|
$10,663,869
241,264 shares
|
— | 30 Sep 2024 |
| Schonfeld Strategic Advisors LLC |
13F
Company
|
0.27%
|
$8,678,669
196,350 shares
|
— | 30 Sep 2024 |
| TD ASSET MANAGEMENT INC |
13F
Company
|
0.27%
|
$8,379,315
192,894 shares
|
— | 30 Sep 2024 |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
Company
|
0.24%
|
$7,761,122
175,591 shares
|
— | 30 Sep 2024 |
| Cutter Capital Management, LP |
13F
Company
|
0.24%
|
$7,641,119
172,876 shares
|
— | 30 Sep 2024 |
| Point72 Asset Management, L.P. |
13F
Company
|
0.24%
|
$7,583,527
171,573 shares
|
— | 30 Sep 2024 |
| Nuveen Asset Management, LLC |
13F
Company
|
0.22%
|
$7,028,861
159,024 shares
|
— | 30 Sep 2024 |
| ExodusPoint Capital Management, LP |
13F
Company
|
0.21%
|
$6,789,000
153,596 shares
|
— | 30 Sep 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
Company
|
0.19%
|
$6,072,594
137,389 shares
|
— | 30 Sep 2024 |
Institutional Holders of Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) as of Q4 2024
As of 31 Dec 2024,
Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) was held by
177 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,912,622 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., FMR LLC, VANGUARD GROUP INC, Sofinnova Investments, Inc., STATE STREET CORP, COMMODORE CAPITAL LP, Holocene Advisors, LP, and SAMLYN CAPITAL, LLC.
This page lists
177
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
172
Q4 2024 holders
177
Holder diff
5
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.